High effectiveness of durvalumab consolidation in stage-III NSCLC: Focus on treatment selection and prognostic factors. Supplementary Tables von Eberhardtb, Wilfried E.E., Stuschkea, Martin, Schulerb, Martin, Aignerd, Clemens, Theegarteni, Dirk, Darwicheh, Kaid, Hautzelf, Hubertus, Herrmannf, Ken, Wettere, Axel, Forstinge, Michael, Plönes, Till, Wiesweg, Marcel, Metzenmacher, Martin, Richlitzkia, Cedric, Gauler, Thomas, Pöttgen, Christoph, Guberina, Nika, Guberina, Maja

Volltext bestellen